Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project
Investigator initiated multi-institutional retrospective review of clinical and radiographic
outcomes after 90Y resin microsphere radioembolization for metastatic colorectal liver
metastases in the USA. The target is for at least 1,000 evaluable patients with 12+ weeks
follow up. Objectives:
Independent data collection and reporting of pre treatment and 12 week post treatment
clinical, radiographic and radiation parameters and outcomes in patients treated in the USA
from 2002-2010. Data beyond 12 weeks will be collected and highly desirable, however as a
minimum all patients will have 12 week follow up.
Observational Model: Case-Only, Time Perspective: Retrospective
Adverse events at day 0-90 post 90Y therapy using CTCae 3.0 criteria.
Multiple systems monitored for side effects possibly related to liver radiotherapy.
Andrew S Kennedy, MD, FACRO
Sarah Cannon Research Institute
United States: Institutional Review Board
|Contact Sarah Cannon||Nashville, Tennessee 37203|